Alterations in lipoxygenase and cyclooxygenase-2 catalytic activity and mRNA expression in prostate carcinoma

Neoplasia

Volumn 3, Issue 4, 2001, Pages 287-303

  Shappell, Scott B ^a,b   Manning, Suzanne ^a,b   Boeglin, William E ^a   Guan, You Fei ^a   Roberts, Richard L ^a,b   Davis, Linda ^a   Olson, Sandra J ^a,b   Jack, Gregory S ^a   Coffey, Christopher S ^a   Wheeler, Thomas M ^c   Breyer, Matthew D ^a,b   Brash, Alan R ^a,b  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b VANDERBILT INGRAM CANCER CENTER   (United States)

^c BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

15 Lipoxygenase 2; Arachidonic acid; Cyclooxygenase; Eicosanoids; HETEs

Indexed keywords

5 HYDROXYICOSATETRAENOIC ACID; ARACHIDONATE 15 LIPOXYGENASE; ARACHIDONIC ACID; CYCLOOXYGENASE 2; ICOSANOID; LIPOXYGENASE; MESSENGER RNA;

ARACHIDONIC ACID METABOLISM; ARTICLE; ENZYME ACTIVITY; ENZYME ASSAY; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MALE; PRIORITY JOURNAL; PROSTATE CARCINOMA; PROSTATE HYPERTROPHY; PROTEIN EXPRESSION; RNA ANALYSIS;

EID: 17944368061     PISSN: 15228002     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.neo.7900166     Document Type: Article

References (52)

1. Differentiation pathways and histogenetic aspects of normal and abnormal prostatic growth: A stem cell model
2. Role of androgen in prostate growth and, regression: Stromal-epithelial interaction
3. Growth factors as mediators of androgen action during male urogenital development
4. Role of peptide growth factors in the prostate: A review
5. 15-Lipoxygenase-2 (15-LOX-2) is expressed in benign prostatic epithelium and reduced in prostate adenocarcinoma
6. Reduced 15-lipoxygenase-2 immunostaining in prostate adenocarcinoma: Correlation with grade and expression in high grade prostatic intraepithelial neoplasia
7. Elevated 12-lipoxygenase mRNA expression correlates with advanced stage and poor differentiation of human prostate cancer
8. Platelet-type 12-lipoxygenase in a human prostate carcinoma stimulates angiogenesis and tumor growth
9. Arachidonic acid stimulates prostate cancer cell growth: Critical role of 5-lipoxygenase
10. 5-Lipoxygenase inhibitors reduce PC-3 cell proliferation and initiate nonnecrotic cell death
11. Inhibition of arachidonate 5-lipoxygenase triggers massive apoptosis in human prostate cancer cells
12. Induction of cyclo-oxygenase-2 mRNA by prostaglandin E2 in human prostatic carcinoma cells
13. NS398, a selective cyclooxygenase-2 inhibitor, induces apoptosis and downregulates bcl-2 expression in LNCaP cells
14. Molecular genetics and epidemiology of prostate carcinoma
15. Fresh tissue harvest for research from prostatectomy specimens
16. Enhanced expression of cyclooxygenase-2 in high grade human transitional cell bladder carcinomas
17. Constitutive expression of cyclooxygenase-2 in rat vas deferens
18. Prostaglandin synthase 2 gene disruption causes severe renal pathology in the mouse
19. Histologic grading and clinical staging of carcinoma of the prostate
20. Prediction of progression following radical prostatectomy. A multivariate analysis of 721 men with long-term follow-up
21. Pathology of androgen deprivation therapy in prostate carcinoma. A comparative study of 173 patients
22. Effect of neoadjuvant endocrine therapy (combined androgen blockade) on normal prostate and prostatic carcinoma. A randomized study
23. Discovery of a, second 15S-lipoxygenase in humans
24. Positional specificity of a reticulocyte lipoxygenase. Conversion of arachidonic acid to 15S-hydroperoxy-eicosatetraenoic acid
25. Calcitriol and transforming growth factor-beta upregulate 5-lipoxygenase mRNA expression by increasing gene transcription and mRNA maturation
26. Lipoxygenase mRNA silencing in erythroid differentiation: The 3′UTR regulatory complex controls 60S ribosomal subunit joining
27. 15-Lipoxygenase-2 (15-LOX-2) expression in benign and neoplastic sebaceous glands and other cutaneous adnexa
28. 15-Hydroxyeicosatetraenoic acid (15-HETE) activates peroxisome proliferator activated receptor gamma (PPARγ) and inhibits proliferation in PC3 prostate carcinoma cells
29. Concordant induction of 15-lipoxygenase-1 and mutant p53 expression in human prostate adenocarcinoma: Correlation with Gleason staging
30. Lipoxygenases: Occurrence, functions, catalysis and acquisition of substrate
31. Endogenous 12S-HETE production by tumor cells and its role in metastasis
32. Tumor derived 12(S)-hydroxyeicosatetraenoic acid induces microvascular endothelial cell retraction
33. 12-Lipoxygenase, 12(S)-HETE and cancer metastasis
34. Aspirin use and reduced risk of fatal colon cancer
35. A hypothesis: Nonsteroidal anti-inflammatory drugs reduce the incidence of large-bowel cancer
36. Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis
37. Upregulation of cyclooxygenase-2 gene expression in human colorectal adenomas and adenocarcinomas
38. Expression of prostaglandin G/H synthase-1 and -2 protein in human colon cancer
39. Prostaglandin H synthase 2 is expressed abnormally in human colon cancer: Evidence for a transcriptional effect
40. Expression of cylooxygenase-2 in human gastric carcinoma
41. Expression of cyclooxygenase-2 in human lung carcinoma
42. Expression of cyclooxygenase-1 and cyclooxygenase-2 in human breast cancer
43. Expression of cyclooxygenase-2 (COX-2) in human invasive transitional cell carcinoma (TCC) of the urinary bladder
44. Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2
45. Cyclooxygenase regulates angiogenesis induced by colon cancer cells
46. Cyclooxygenase inhibitors suppress angiogenesis and reduce tumor growth in vivo
47. Antiangiogenic and antitumor activities of cyclooxygenase-2 inhibitors
48. Over-expression of cyclooxygenase-2 in human prostate adenocarcinoma
49. Expression of cyclooxygenase-2 in prostate carcinoma
50. Differential expression of cyclooxygenase-2 and its regulation by tumor necrosis factor-α in normal and malignant prostate cells
51. Inhibition of cyclooxygenase-2 suppresses angiogenesis and the growth of prostate cancer in vivo
52. Effects of ligand activation of peroxisome proliferator-activated receptor gamma in human prostate cancer